Heiyoun Jung

1 Patent

• US117448222023

  Reducing Tumor Burden by Administering CCR1 Antagonists in Combination with PD-1 Inhibitors or PD-L1 Inhibitors

  CHEMOCENTRYX, Inc.

  0 cites